| Citation: |
WANG Yajuan, WANG Yuan, REN Xinyu. Correlation of CD117 and DOG1 Expression with the Clinicopathological Features and Prognosis in Triple-negative Breast Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 616-623. DOI: 10.12290/xhyxzz.2023-0454
|
To investigate the expression of CD117 and DOG1 in triple-negative breast cancer (TNBC) and to explore their relationship with clinicopathologic features and prognosis.
The patients with TNBC in Peking Union Medical College Hospital from 2000 to 2011 were retrospectively collected and tissue microarrays were made. The expression of CD117 and DOG1 in tumor cells was detected by immunohistochemistry to analyze their relationship with the clinicopathological characteristics of the patients, such as age, tumor diameter, American Joint Committee on Cancer (AJCC) cancer stage, histological grade, P53, and Ki-67 proliferation index, and explore the effect of both on the survival of patients.
A total of 185 TNBC patients meeting the inclusion and exclusion criteria were selected, of which 24 (12.97%) were CD117 positive and 22 (11.89%) were DOG1 positive, with a co-expression rate of 1.62%. Compared with CD117-negative patients, CD117-positive patients had higher Ki-67 proliferation index (87.50% vs. 67.70%, P=0.048), basal-like TNBC (95.83% vs. 74.53%, P=0.020), and P53 diffuse positive (33.33% vs. 13.66%, P=0.032).Compared with DOG1-negative patients, DOG1-positive patients had lower proportions of tumor diameter ≤2 cm (22.73% vs. 45.40%, P=0.026) and basal-like TNBC (54.55% vs. 80.37%, P=0.015). The median follow-up was 71 months (range: 2-170 months), 4 cases (2.16%) were lost to follow-up, 66 cases (35.68%) relapsed or had distant metastasis, and 34 cases (18.38%) died. Survival analysis showed that AJCC stage (HR=7.624, 95% CI: 2.187-26.576, P=0.001) and CD117 positive with P53 diffuse strong positive (HR=3.942, 95% CI: 1.366-11.379, P=0.011) were negatively correlated with the overall survival of TNBC patients.
The expression of CD117 and DOG1 were significantly related to basal-like TNBC, CD117 positive with P53 diffuse strong positive may be correlated with a shorter overall survival and a higher mortality risk.
| [1] |
Borri F, Granaglia A. Pathology of triple negative breast cancer[J]. Semin Cancer Biol, 2021, 72: 136-145. DOI: 10.1016/j.semcancer.2020.06.005
|
| [2] |
Funkhouser A T, Strigenz A M, Blair B B, et al. KIT mutations correlate with higher galectin levels and brain metastasis in breast and non-small cell lung cancer[J]. Cancers (Basel), 2022, 14(11): 2781. DOI: 10.3390/cancers14112781
|
| [3] |
Roskoski R, Jr. Properties of FDA-approved small molecule protein kinase inhibitors: a 2023 update[J]. Pharmacol Res, 2023, 187: 106552. DOI: 10.1016/j.phrs.2022.106552
|
| [4] |
Luo Y L, Huang W T, Zhang H Z, et al. Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer[J]. Oncol Lett, 2018, 15(5): 6161-6170.
|
| [5] |
Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity[J]. Science, 2008, 322(5901): 590-594. DOI: 10.1126/science.1163518
|
| [6] |
Bae J S, Park J Y, Park S H, et al. Expression of ANO1/DOG1 is associated with shorter survival and progression of breast carcinomas[J]. Oncotarget, 2017, 9(1): 607-621.
|
| [7] |
Jansen K, Farahi N, Büscheck F, et al. DOG1 expression is common in human tumors: a tissue microarray study on more than 15, 000 tissue samples[J]. Pathol Res Pract, 2021, 228: 153663. DOI: 10.1016/j.prp.2021.153663
|
| [8] |
Nielsen T O, Leung S C Y, Rimm D L, et al. Assessment of Ki67 in breast cancer: updated recommendations from the international Ki67 in breast cancer working group[J]. J Natl Cancer Inst, 2021, 113(7): 808-819. DOI: 10.1093/jnci/djaa201
|
| [9] |
Rakha E A, Ellis I O. Triple-negative/basal-like breast cancer: review[J]. Pathology, 2009, 41(1): 40-47. DOI: 10.3969/j.issn.1007-8096.2009.01.012
|
| [10] |
Sheikh E, Tran T, Vranic S, et al. Role and significance of c-Kit receptor tyrosine kinase in cancer: a review[J]. Bosn J Basic Med Sci, 2022, 22(5): 683-698.
|
| [11] |
Nielsen T O, Hsu F D, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16): 5367-5374. DOI: 10.1158/1078-0432.CCR-04-0220
|
| [12] |
Schulmeyer C E, Fasching P A, Häberle L, et al. Expression of the immunohistochemical markers CK5, CD117, and EGFR in molecular subtypes of breast cancer correlated with prognosis[J]. Diagnostics (Basel), 2023, 13(3): 372. DOI: 10.3390/diagnostics13030372
|
| [13] |
Kriegsmann K, Flechtenmacher C, Heil J, et al. Immunohistological expression of SOX-10 in triple-negative breast cancer: a descriptive analysis of 113 samples[J]. Int J Mol Sci, 2020, 21(17): 6407. DOI: 10.3390/ijms21176407
|
| [14] |
Mitri Z I, Abuhadra N, Goodyear S M, et al. Impact of TP53 mutations in triple negative breast cancer[J]. NPJ Precis Oncol, 2022, 6(1): 64. DOI: 10.1038/s41698-022-00303-6
|
| [15] |
Pan Y B, Yuan Y F, Liu G S, et al. P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients[J]. PLoS One, 2017, 12(2): e0172324. DOI: 10.1371/journal.pone.0172324
|
| [16] |
Jansson S, Bendahl P O, Grabau D A, et al. The three receptor tyrosine kinases c-Kit, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased protein expression in triple-negative breast cancer[J]. PLoS One, 2014, 9(7): e102176. DOI: 10.1371/journal.pone.0102176
|
| [1] | MA Xing, LIU Chang. Prognosis and Treatment Strategies of FIGO 2018 Stage ⅢC Cervical Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1253-1260. DOI: 10.12290/xhyxzz.2024-0097 |
| [2] | ZHOU Gaosheng, WANG Xiaoting, LIU Jingjing, ZHANG Hongmin, ZHANG Qing, LIU Dawei. Relationship between Oxygen Extraction Ratio and Prognosis in Septic Shock Patients During Early Resuscitation[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1217-1223. DOI: 10.12290/xhyxzz.2023-0008 |
| [3] | LIU Huan, HUANG Xiaoling, DAI Mengying, GUO Jiejie, GAO feng. Clinical Characteristics and Inflammatory Markers of Omicron BA.5.2 Variant Infection in Hospitalized Patients and Their Predictive Role in Disease Prognosis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1038-1045. DOI: 10.12290/xhyxzz.2023-0055 |
| [4] | ZHANG Ning, ZHU Wen-ling, LIU Xiao-hong, CHEN Wei, KANG Jun-ren, ZHU Ming-lei, TIAN Ran. Impact of Frailty on the Short-term Prognosis of Hospitalized Elderly Patients with Coronary Heart Disease:A Prospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 59-66. DOI: 10.12290/xhyxzz.20190150 |
| [5] | Jian-hua DENG, Han-zhong LI. Clinical Diagnosis and Prognosis of Metastatic Pheochromocytoma and Paraganglioma[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(6): 654-659. DOI: 10.3969/j.issn.1674-9081.2019.06.018 |
| [6] | Jia-qi ZHANG, Lei LIU, Gui-ge WANG, Wen-liang BAI, Shan-qing LI. Clinical Pathological Features and Prognosis of Non-small Cell Lung Cancer with Skip N2 Lymph Node Metastasis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 272-277. DOI: 10.3969/j.issn.1674-9081.2019.03.015 |
| [7] | Ran ZHOU, Tong-juan ZOU, Wan-hong YIN, Yao QIN, Yi LI, Jing YANG, Yan KANG. nfluence of Mitral Regurgitation on the Prognosis of Patients with Septic Shock[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 426-430. DOI: 10.3969/j.issn.1674-9081.2018.05.010 |
| [8] | Cheng HUANG, Ye-ye CHEN, Shan-qing LI, Xiao-yun ZHOU, Hong-sheng LIU, Li LI, Ying-zhi QIN, Jia HE, Dong-jie MA. Ectopic Adrenocorticotropic Hormone Syndrome Caused by Thoracic Neuroendocrine Tumors: Surgical Treatment and Prognosis Factors[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(2-3): 147-153. DOI: 10.3969/j.issn.1674-9081.2017.03.012 |
| [9] | Qing-yuan DENG, Yi-cong YE, Ying ZHONG, Miao-miao SHENG, Feng-ming HUANG, Cheng-yu JIANG, Shu-yang ZHANG. Angiotensin Ⅱ in Predicting the In-hospital Prognosis of Patients Undergoing Elective Percutaneous Coronary Intervention[J]. Medical Journal of Peking Union Medical College Hospital, 2016, 7(1): 13-17. DOI: 10.3969/j.issn.1674-9081.2016.01.003 |
| [10] | Yu YANG, Quan-zong MAO, Han-zhong LI, Zhi-gang JI, Wei-gang YAN, Shi RONG, Guang-hua LIU, Wei-feng XU, He XIAO, Hui-jun WANG. Clinical Features and Prognosis of Paraneoplastic Syndromes in Renal Malignancies[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(2): 195-199. DOI: 10.3969/j.issn.1674-9081.2012.02.014 |
| 1. |
李晓诗，罗琴，周庆，钟科，蒋安科，夏林玉，胡清林. 三阴性乳腺癌人类白细胞抗原-G抑制T细胞免疫功能机制的研究. 中国临床研究. 2024(10): 1499-1505 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: